ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0370

Awareness and Attitudes Regarding Axial Spondyloarthritis Among Primary Care Providers

Yuliya Afinogenova1, Swetha Ann Alexander2, Narinder Maheshwari3, Sonam Kiwalkar4 and Abhijeet Danve5, 1Yale School of Medicine, Hamden, CT, 2University of Connecticut, Hartford, CT, 3UConn Health, West Hartford, CT, 4The Vancouver Clinic, Portland, OR, 5Yale University, Rocky Hill, CT

Meeting: ACR Convergence 2021

Keywords: Access to care, Back pain, spondyloarthritis, Surveys

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: There is significant discrepancy between population and diagnostic prevalence of axial spondyloarthritis (axSpA) and ankylosing spondylitis (AS) in the US. Delayed and missed diagnosis of axSpA in clinical practice may result from lack of timely referral by non-rheumatologists. Primary care providers (PCPs) are the main source for referral of back pain patients to rheumatologists in the US. In this study, we aim to assess knowledge, awareness and attitudes about axSpA among PCPs to identify gaps in knowledge and devise strategies for early referral.

Methods: In this ongoing study, we distributed a HIPAA compliant secure electronic survey created through Yale Qualtrics Survey tool to select PCPs within several academic institutions and affiliated practices. Our survey includes questions on demographics, practice setting, practice patterns and knowledge assessment surrounding axSpA.

Results: One hundred and thirty-eight providers completed the survey, with response rate of 40%. Among respondents, 68% were female, 76% MDs and 24% advanced practioners. Practice setting included 21% in academic practice and 46% in multi-specialty group. PCPs at different stages in their careers were surveyed. Twenty two percent saw < 30 patients/week, 55% saw 30-60 patients/week and 22% saw 61-90 patients/week. Ninety six percent were at least somewhat familiar with the term inflammatory back pain (IBP). Fifty eight percent reported that they never or rarely assess for IBP; 40% reported that they are not comfortable with making the diagnosis of IBP. Majority (83%) never or rarely ordered HLA B27, and 65% never or rarely ordered CRP for young patients with chronic back pain. Seventy six percent ordered X-ray lumbar spine at least often, and 54% rarely or never ordered MRI lumbar spine in chronic back pain patients. Seventy two percent rarely or never ordered X-ray sacroiliac joint and 97% rarely or never ordered MRI sacroiliac joint. At least fifty percent reported that they never or rarely asked about peripheral arthritis, psoriasis or inflammatory back pain, and at least 75% reported that they rarely or never asked about uveitis or enthesitis. Fifty percent of the providers reported that they never or rarely asked about family history of spondyloarthritis. Forty six percent were not familiar with the change in nomenclature around the terms axSpA and AS. Forty percent were not comfortable with making diagnosis of AS, and seventy percent were not comfortable with making diagnosis of AxSpA.

Conclusion: Our preliminary results confirm lack of knowledge and awareness regarding IBP and changed nomenclature of axSpA among PCPs. PCPs may not be evaluating chronic back pain patients for axSpA, which can contribute to lack of referral and delay in diagnosis.


Disclosures: Y. Afinogenova, None; S. Alexander, None; N. Maheshwari, None; S. Kiwalkar, None; A. Danve, Abbvie, 1, Novartis, 5, 6.

To cite this abstract in AMA style:

Afinogenova Y, Alexander S, Maheshwari N, Kiwalkar S, Danve A. Awareness and Attitudes Regarding Axial Spondyloarthritis Among Primary Care Providers [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/awareness-and-attitudes-regarding-axial-spondyloarthritis-among-primary-care-providers/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/awareness-and-attitudes-regarding-axial-spondyloarthritis-among-primary-care-providers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology